About this trial
1. To evaluate the clinical outcomes of ultrasound-guided thermal ablation and thyroid surgery for the treatment of papillary thyroid carcinoma; 2. To develop and validate a artificial intelligence model to predict the outcomes of ultrasound-guided thermal ablation in the treatment of papillary thyroid carcinoma;
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
patients age between 18 and 80 year old, both sex
papillary thyroid carcinoma confirmed by core-needle biopsy or fine-needle aspiration
the largest diameter ≤2.0 cm
no clinical or imaging evidences of extrathyroidal extension, lymph node metastasis and distant metastasis on ultrasound, nech and chest CT
Disqualifiers
patients with convincing evidence of aggressive papillary thyroid carcinoma or other type of thyroid cancer by biopsy
history of neck radiation
history of thyroid surgery
coagulation disorder
Trial population
patients with low-risk papillary thyroid carcinoma who choose surgery or thermal ablation
Trial design
Cohort
Prospective
Treatments tested in this trial
thyroid surgery
Procedure/Surgerythyroid lobectomy
ultrasound-guided thermal ablation
Procedure/Surgeryradiofrequency ablation; microwave ablation or laser ablation
Treatment groups
Trial outcomes
Primary outcomes
rate of disease progression
cervical lymph node metastases, recurrent tumors and persistent tumors
Secondary outcomes
Rate of complications
surgery or ablation complications
Rate of tumor disappearance
complete disappearance of ablated tumor on ultrasound and contrast-enhanced ultrasound
Sponsors and contacts
Click on the lead sponsor to view all of their trials.